Fundraising FoxE9 Genomics
1 known investors
Find your way into E9 Genomics
Sign up to see every warm intro you have to E9 Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the E9 Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
E9 Genomics builds Urchin, an agentic biological search and reasoning platform that autonomously searches, integrates, and reasons over public and private biological data to help biopharma teams find non-obvious, high-value opportunities. It serves drug discovery teams for use cases such as indication selection, drug repurposing, and target prioritization, and currently operates as a collaborative service deploying Urchin on client projects.
Investors · 1
Frequently asked questions
- What does E9 Genomics do?
- E9 Genomics builds Urchin, an agentic biological search and reasoning platform that autonomously searches, integrates, and reasons over public and private biological data to help biopharma teams find non-obvious, high-value opportunities. It serves drug discovery teams for use cases such as indication selection, drug repurposing, and target prioritization, and currently operates as a collaborative service deploying Urchin on client projects.
- Who are E9 Genomics's investors?
- E9 Genomics's investors include Mute Ventures.